| ACC/AHA | American College of Cardiology/American Heart Association |
| ACCP | Anti-cyclic citrullinated peptide antibodies |
| ACR | American College of Rheumatology |
| ACS | Acute coronary syndrome |
| AF | Atrial fibrillation |
| ApoA-I | Apolipoprotein A-I |
| ApoB | Apolipoprotein B |
| AS | Aortic stenosis |
| ASA | Acetylsalicylic acid |
| AUC | Area under the curve |
| BAFF | B-cell activating factor |
| BMI | Body mass index |
| CCL-7 (MCP3) | Monocyte chemotactic protein 3 |
| CDAI | Clinical disease activity index (for rheumatoid arthritis) |
| CD163 | Cluster of differentiation 163 |
| CHR | High-sensitive CRP:HDL-cholesterol ratio |
| CI | Confidence interval |
| CRP | C-reactive protein |
| CS | Corticosteroids |
| CV | Cardiovascular |
| CVD | Cardiovascular disease |
| CVR | Cardiovascular risk |
| DAS28 | Disease activity score 28 for rheumatoid arthritis |
| DMARD | Disease-modifying anti-rheumatic drug |
| ED | Endothelial dysfunction |
| ELAM-1 | Endothelial leukocyte adhesion molecule-1 |
| ERS-RA | The expanded risk score in rheumatoid arthritis |
| ESC | European Society of Cardiology |
| ESR | Erythrocyte sedimentation rate |
| FRS | Framingham risk score |
| HAQ | Health assessment questionnaire |
| HAQ-DI | Health assessment questionnaire disability index |
| HDL | High-density lipoprotein |
| HDL2-C | HDL fraction 2 |
| HDL3-C | HDL fraction 3 |
| HF | Heart failure |
| HFpEF | Heart failure with preserved ejection fraction |
| HLA-DR1 | Human leukocyte antigen DR-1 |
| HIV | Human immunodeficiency virus |
| HR | Hazard ratio |
| ICAM-1 | Inter-cellular adhesion molecule 1 |
| IL-1,6,8,17 | Interleukin 1, 6, 8, 17 |
| IS | Ischemic stroke |
| LDL | Low-density lipoprotein |
| IMA | Ischemia-modified albumin |
| IMT | Intima–media thickness |
| MACE | Major adverse cardiovascular events |
| MCP | Metacarpophalangeal joint |
| METS-VF | Metabolic score for visceral fat |
| MFR | Myocardial flow reserve |
| MHC | Major histocompatibility complex |
| MI | Myocardial infarction |
| NET | Neutrophil extra-cellular trap |
| NSAID | Non-steroidal anti-inflammatory drug |
| OA | Osteoarthritis |
| OR | Odds ratio |
| QRISK2,3 | Cardiovascular risk score |
| PAD | Peripheral artery disease |
| RA | Rheumatoid arthritis |
| RF | Rheumatoid factor |
| ROC | Receiver operating characteristic |
| RS | Reynolds risk score |
| RSN | Reactive species of nitrogen |
| RSO | Reactive species of oxygen |
| RV | Rheumatoid vasculitis |
| SAVR | Surgical aortic valve replacement |
| sCD163 | Soluble cluster of differentiation 163 |
| SCORE | Systematic COronary Risk Evaluation |
| SR-B1 | Scavenger receptor, class B type 1 |
| T2DM | Type 2 diabetes mellitus |
| TAVR | Transcatheter aortic valve replacement |
| TC | Total cholesterol |
| TG | triglycerides |
| TNF-α | Tumor necrosis factor-α |
| VCAM-1 | Vascular cell adhesion molecule 1 |